Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis.

Literature DB >> 10647880

Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis.

J Bolaños-Meade¹, Y K Keung, C López-Arvizu, R Florendo, E Cobos.

Abstract

The combination of sickle cell disease crisis and thrombotic thrombocytopenic purpura has been described only a few times. Here we present the case of a patient with a hemolytic crisis due to sickle cell disease complicated by thrombotic thrombocytopenic purpura. We also review the cases previously reported and compare and contrast them, highlighting diagnostic challenges.

Entities: Disease Species

Mesh：

Year: 1999 PMID： 10647880 DOI： 10.1007/s002770050558

Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673

Keyword Cloud
Cited

10 in total

1. Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease.

Authors: Enrico M Novelli; Gregory J Kato; Mariana E Hildesheim; Suchitra Barge; Michael P Meyer; Jay Lozier; Andrea Cortese Hassett; Margaret V Ragni; Jeffrey S Isenberg; Mark T Gladwin
Journal: Haematologica Date: 2013-11 Impact factor: 9.941

2. Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.

Authors: Satheesh Chonat; Shanmuganathan Chandrakasan; Karen Ann Kalinyak; David Ingala; Ralph Gruppo; Theodosia A Kalfa
Journal: Br J Haematol Date: 2015-12-21 Impact factor: 6.998

3. What is behind a relapse of thrombotic thrombocytopenic purpura?

Authors: Marco Capecchi; Andrea Artoni; Maria Domenica Cappellini; Giovanna Graziadei
Journal: Intern Emerg Med Date: 2017-11-02 Impact factor: 3.397

4. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.

Authors: Junmei Chen; William E Hobbs; Jennie Le; Peter J Lenting; Philip G de Groot; José A López
Journal: Blood Date: 2011-02-07 Impact factor: 22.113

5. Sickle cell disease and venous thromboembolism.

Authors: Zohreh Rahimi; Abbas Parsian
Journal: Mediterr J Hematol Infect Dis Date: 2011-05-24 Impact factor: 2.576

6. Coagulopathy and functional hyposplenism during an episode of thrombotic thrombocytopenic purpura in a HgbS/β (+)-thalassemia patient.

Authors: Andrew J Gangemi; Peter V Pickens
Journal: Clin Case Rep Date: 2015-05-05

Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis.

1. Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease.

2. Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.

3. What is behind a relapse of thrombotic thrombocytopenic purpura?

4. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.

5. Sickle cell disease and venous thromboembolism.

6. Coagulopathy and functional hyposplenism during an episode of thrombotic thrombocytopenic purpura in a HgbS/β (+)-thalassemia patient.

Review 7. Acute Chest Syndrome in Children with Sickle Cell Disease.

8. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.

9. TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange.

10. Fat Embolism Syndrome in Sickle Cell Disease.